Product Information
MUCUS RLF DM ER 600-30 MG TAB is a generic product labeled by Cardinal Health, priced at $0.3591 per EA under NDC 70000049101. Its NADAC has been published 344 times since Jan 22, 2020.
FDA first approved this application on Nov 1, 2018.
Strength
30; 600 mg/1; mg/1
Manufacturer
Cardinal HealthNDC
70000049101
Classification
Generic
Dosage Form
TABLET
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
DEXTROMETHORPHAN HYDROBROMIDE; GUAIFENESINApproval Type
Generic (ANDA)
FDA Application
ANDA209692FDA Approved
11/1/2018
On Market Since
1/31/2019
Pharmacological Classes
Price Statistics
The NADAC for MUCUS RLF DM ER 600-30 MG TAB has been published 344 times since Jan 22, 2020, and over the history we have for it it has declined 21.2%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.3591 per EA |
|---|---|
| All-time high | $0.5070 (Sep 16, 2020) |
| All-time low | $0.3481 (Feb 18, 2026) |
| 52-week high | $0.4072 |
| 52-week low | $0.3481 |
| Median price | $0.4275 |
| Average price | $0.4241 |
| Largest weekly change | +17.4% (May 19, 2021) |
| Weeks tracked | 344 |
| Tracking since | Jan 22, 2020 |
1W
N/A
1M
N/A
3M
-7.8%
6M
-1.4%
1Y
-11.8%
3Y
-12.2%
5Y
-12.6%
All
-21.2%
Last surveyed Aug 19, 2026 — this NDC no longer appears in the current weekly NADAC file.
Generic Alternatives
The matcher finds 2 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 1% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Cardinal Health manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Guaifenesin, Dextromethorphan HBr market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Expectorant class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of MUCUS RLF DM ER 600-30 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for MUCUS RLF DM ER 600-30 MG TAB, manufactured by Cardinal Health, is $0.3591 per EA (NDC 70000049101), effective Aug 19, 2026.
How has the price of MUCUS RLF DM ER 600-30 MG TAB changed over time?
Over the history we have for it, the NADAC for MUCUS RLF DM ER 600-30 MG TAB has declined 21.2%. It has been tracked across 344 weekly CMS publications since Jan 22, 2020.
What are the highest and lowest recorded NADAC prices for MUCUS RLF DM ER 600-30 MG TAB?
Since Jan 22, 2020, the NADAC for MUCUS RLF DM ER 600-30 MG TAB has ranged from a low of $0.3481 (Feb 18, 2026) to a high of $0.5070 (Sep 16, 2020), with a median of $0.4275 per EA.
Are there cheaper alternatives to MUCUS RLF DM ER 600-30 MG TAB?
Yes. 2 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, MUCUS RLF DM ER 600-30 MG TAB, is $0.3560 per EA — about 1% below MUCUS RLF DM ER 600-30 MG TAB.
Who manufactures MUCUS RLF DM ER 600-30 MG TAB?
MUCUS RLF DM ER 600-30 MG TAB (NDC 70000049101) is labeled by Cardinal Health, and CMS classifies it as a generic product.